Solid international R&D strength

      We have established a cooperative relationship with TheNewZealand Institute for Plant and FoodResearch, set up the maxhealthbio Global Research Institute in NewZealand, and established a technology development center and a pilot plant. Serving the company's global production plants of omega-3, 6 and other fatty acids and affiliated industries. After years of technological exploration and accumulation, the research institute has broken the industry's technological monopoly and blazed a trail of industry-university-research cooperation that belongs to Meisihe. It has adopted advanced proprietary technologies such as the latest generation of molecular distillation and molecular dynamics simulation technology TF-MDST, as well as the unique biological expression processing technology TF-HTST, to build an industry-leading digital and intelligent platform. We offer Omega-3 and Omega-6 products (including EPA, DHA, DPA, etc.) with content ranging from 30% to 98%, covering types such as ethyl ester type (EE) and triglyceride type (including r-TG, n-TG). We guarantee that our products achieve outstanding qualities such as medical-grade purity, high bioavailability, low fishy smell, and stable impurity control, providing customers with the most valuable product experience and "one-stop" technical solutions.

Research Institute

Technology Development Center

Digital Intelligence Platform

Pilot Plant Factory